Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote HKD

Akeso, Inc. (9926.HK)

Compare
82.950
-0.750
(-0.90%)
At close: April 17 at 4:08:07 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,526,253
4,526,253
837,656
225,626
--
Cost of Revenue
133,248
133,248
94,117
31,259
--
Gross Profit
4,393,005
4,393,005
743,539
194,367
--
Operating Expense
2,226,181
2,226,181
1,965,561
1,460,801
952,423
Operating Income
2,166,824
2,166,824
-1,222,022
-1,266,434
-952,423
Net Non Operating Interest Income Expense
32,746
32,746
-21,318
3,884
26,518
Pretax Income
1,942,525
1,942,525
-1,422,216
-1,258,126
-1,320,579
Tax Provision
174
174
--
--
--
Net Income Common Stockholders
2,028,300
2,028,300
-1,168,393
-1,074,933
-1,036,374
Diluted NI Available to Com Stockholders
2,028,300
2,028,300
-1,168,393
-1,074,933
-1,036,374
Basic EPS
2.42
--
-1.42
-1.32
-1.65
Diluted EPS
2.42
--
-1.42
-1.32
-1.65
Basic Average Shares
837,683.779
--
824,989.858
815,931.798
628,941.610
Diluted Average Shares
837,821.477
--
824,989.858
815,931.798
628,941.610
Rent Expense Supplemental
2,683
--
--
--
--
Total Expenses
2,359,429
2,359,429
2,059,678
1,492,060
952,423
Net Income from Continuing & Discontinued Operation
2,028,300
2,028,300
-1,168,393
-1,074,933
-1,177,051
Normalized Income
1,976,198.667
1,976,198.667
-1,174,497
-1,083,455
-1,184,074
Interest Income
119,733
119,733
21,972
14,236
34,505
Interest Expense
86,987
86,987
43,290
10,352
7,987
Net Interest Income
32,746
32,746
-21,318
3,884
26,518
EBIT
2,029,512
2,029,512
-1,378,926
-1,247,774
-1,312,592
EBITDA
2,172,280
2,172,280
-1,273,137
-1,189,531
-1,290,485
Reconciled Cost of Revenue
133,248
133,248
94,117
31,259
--
Reconciled Depreciation
142,768
142,768
105,789
58,243
22,107
Net Income from Continuing Operation Net Minority Interest
2,028,300
2,028,300
-1,168,393
-1,074,933
-1,177,051
Total Unusual Items Excluding Goodwill
52,106
52,106
6,104
8,522
7,023
Total Unusual Items
52,106
52,106
6,104
8,522
7,023
Normalized EBITDA
2,120,174
2,120,174
-1,279,241
-1,198,053
-1,297,508
Tax Rate for Calcs
0
0
--
--
--
Tax Effect of Unusual Items
4.667
4.667
--
--
--
12/31/2020 - 4/24/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1801.HK INNOVENT BIO
47.250
+2.38%
 
6160.HK BeiGene, Ltd.
139.700
-0.36%
 
2269.HK WuXi Biologics (Cayman) Inc.
20.500
+1.49%
 
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
285.400
-1.25%
 
9688.HK Zai Lab Limited
22.800
-1.30%
 
2616.HK CStone Pharmaceuticals
2.510
+0.40%
 
1530.HK 3SBIO
11.960
-0.83%
 
9606.HK Duality Biotherapeutics, Inc.
200.000
+6.84%
 
1177.HK SINO BIOPHARM
3.670
+1.66%
 
1952.HK Everest Medicines Limited
47.100
+1.07%